Preliminary report: Measurement of apixaban and rivaroxaban in plasma from bleeding patients
Author:
Affiliation:
1. Metropolitan University College; Copenhagen Denmark
2. Department of Clinical Biochemistry; Rigshospitalet; Copenhagen Denmark
3. Department of Immunology; Rigshospitalet; Copenhagen Denmark
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12942/fullpdf
Reference17 articles.
1. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events;Mekaj;Ther Clin Risk Manag,2015
2. New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness;Mani;Drug Des Devel Ther,2014
3. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation;Heidbuchel;Europace,2015
4. Do new oral anticoagulants require laboratory monitoring? The clinician point of view;Samama;Thromb Res,2012
5. Acute-onset severe gastrointestinal tract hemorrhage in a postoperative patient taking rivaroxaban after total hip arthroplasty - a case report;Boland;J Med Case Rep,2012
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A synergy of liquid chromatography with high‐resolution mass spectrometry and coagulation test for determination of direct oral anticoagulants for clinical and toxicological purposes;Biomedical Chromatography;2021-06-21
2. Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation;Journal of the American Geriatrics Society;2021-01-11
3. Optimization of the Extraction Procedure of Apixaban from Dried Rat Plasma Spots;Journal of Pharmaceutical Research International;2020-04-20
4. Pharmacokinetic and Pharmacodynamic Drug Monitoring of Direct-Acting Oral Anticoagulants: Where Do We Stand?;Therapeutic Drug Monitoring;2019-04
5. Reversing anti-factor Xa agents and the unmet needs in trauma patients;BLOOD;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3